BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31165554)

  • 41. Signal Increase on Unenhanced T1-Weighted Images in the Rat Brain After Repeated, Extended Doses of Gadolinium-Based Contrast Agents: Comparison of Linear and Macrocyclic Agents.
    Jost G; Lenhard DC; Sieber MA; Lohrke J; Frenzel T; Pietsch H
    Invest Radiol; 2016 Feb; 51(2):83-9. PubMed ID: 26606548
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does renal function affect gadolinium deposition in the brain?
    Rahatli FK; Donmez FY; Kibaroglu S; Kesim C; Haberal KM; Turnaoglu H; Agildere AM
    Eur J Radiol; 2018 Jul; 104():33-37. PubMed ID: 29857863
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Higher magnetic susceptibility of globus pallidus in patients after macrocyclic GBCAs: assessment using quantitative susceptibility mapping.
    Zhang J; Xie L; Yang X; Xu L; Chen K; Luo Y; Yu C
    Acta Radiol; 2023 Jul; 64(7):2261-2267. PubMed ID: 36567675
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gadolinium deposition in the brain: association with various GBCAs using a generalized additive model.
    Bae S; Lee HJ; Han K; Park YW; Choi YS; Ahn SS; Kim J; Lee SK
    Eur Radiol; 2017 Aug; 27(8):3353-3361. PubMed ID: 28083696
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of Exposure to Gadodiamide and Brain Irradiation on T
    Mallio CA; Parillo M; Zobel BB; Parizel PM; Quattrocchi CC
    J Magn Reson Imaging; 2020 Nov; 52(5):1525-1530. PubMed ID: 32478956
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative assessment of gadolinium deposition in dentate nucleus using quantitative susceptibility mapping.
    Hinoda T; Fushimi Y; Okada T; Arakawa Y; Liu C; Yamamoto A; Okada T; Yoshida K; Miyamoto S; Togashi K
    J Magn Reson Imaging; 2017 May; 45(5):1352-1358. PubMed ID: 27664936
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is There Long-term Signal Intensity Increase in the Central Nervous System on T1-weighted Images after MR Imaging with the Hepatospecific Contrast Agent Gadoxetic Acid? A Cross-sectional Study in 91 Patients.
    Kahn J; Posch H; Steffen IG; Geisel D; Bauknecht C; Liebig T; Denecke T
    Radiology; 2017 Mar; 282(3):708-716. PubMed ID: 28076722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gadoxetate disodium, a modern hepatospecific MRI contrast agent: Indirect signs for gadolinium deposition in the brain structures with signal intensity increase after intravenous application.
    Holesta M; Weichet J; Wagnerova MG; Lukavsky J; Malikova H
    Neurol India; 2018; 66(6):1771-1775. PubMed ID: 30504579
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Effect of Gadolinium-Based Contrast Agents on Longitudinal Changes of Magnetic Resonance Imaging Signal Intensities and Relaxation Times in the Aging Rat Brain.
    Green C; Jost G; Frenzel T; Boyken J; Schwenke C; Pietsch H
    Invest Radiol; 2022 Jul; 57(7):453-462. PubMed ID: 35125411
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extent of Signal Hyperintensity on Unenhanced T1-weighted Brain MR Images after More than 35 Administrations of Linear Gadolinium-based Contrast Agents.
    Zhang Y; Cao Y; Shih GL; Hecht EM; Prince MR
    Radiology; 2017 Feb; 282(2):516-525. PubMed ID: 27513848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Signal intensity change on unenhanced T1-weighted images in dentate nucleus following gadobenate dimeglumine in patients with and without previous multiple administrations of gadodiamide.
    Ramalho J; Semelka RC; AlObaidy M; Ramalho M; Nunes RH; Castillo M
    Eur Radiol; 2016 Nov; 26(11):4080-4088. PubMed ID: 26911888
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Signal Intensity Evaluation in the Dentate Nucleus and Subcortical Gray Matter : Effect of Several Administrations of Gadoterate Meglumine in Multiple Sclerosis.
    Hannoun S; Kocevar G; Codjia P; Maucort-Boulch D; Cotton F; Vukusic S; Durand-Dubief F; Sappey-Marinier D
    Clin Neuroradiol; 2022 Sep; 32(3):677-685. PubMed ID: 33630120
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Global and Regional Brain Assessment with Quantitative MR Imaging in Patients with Prior Exposure to Linear Gadolinium-based Contrast Agents.
    Kuno H; Jara H; Buch K; Qureshi MM; Chapman MN; Sakai O
    Radiology; 2017 Apr; 283(1):195-204. PubMed ID: 27797676
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gadolinium deposition in the paediatric brain: T1-weighted hyperintensity within the dentate nucleus following repeated gadolinium-based contrast agent administration.
    Young JR; Orosz I; Franke MA; Kim HJ; Woodworth D; Ellingson BM; Salamon N; Pope WB
    Clin Radiol; 2018 Mar; 73(3):290-295. PubMed ID: 29208312
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material.
    Kanda T; Ishii K; Kawaguchi H; Kitajima K; Takenaka D
    Radiology; 2014 Mar; 270(3):834-41. PubMed ID: 24475844
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gadolinium Presence in the Brain After Administration of the Liver-Specific Gadolinium-Based Contrast Agent Gadoxetate: A Systematic Comparison to Multipurpose Agents in Rats.
    Jost G; Frenzel T; Boyken J; Schoeckel L; Pietsch H
    Invest Radiol; 2019 Aug; 54(8):468-474. PubMed ID: 30932931
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reliability of signal intensity in the basal ganglia on non-contrast T1-weighted MR scans after repetitive application of a gadolinium-based contrast agent in pediatric neuro-oncology patients.
    Hojreh A; Mulabdic A; Furtner J; Krall C; Pogledic I; Peyrl A; Baltzer PAT
    Eur J Radiol; 2023 Dec; 169():111179. PubMed ID: 37949021
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Signal Change in the Dentate Nucleus on T1-Weighted MR Images After Multiple Administrations of Gadopentetate Dimeglumine Versus Gadobutrol.
    Cao Y; Huang DQ; Shih G; Prince MR
    AJR Am J Roentgenol; 2016 Feb; 206(2):414-9. PubMed ID: 26700156
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diffusion-weighted imaging of the dentate nucleus after repeated application of gadolinium-based contrast agents in multiple sclerosis.
    Eisele P; Szabo K; Ebert A; Radbruch A; Platten M; Schoenberg SO; Gass A
    Magn Reson Imaging; 2019 May; 58():1-5. PubMed ID: 30630068
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measurements of signal intensity of globus pallidus and dentate nucleus suggest different deposition characteristics of macrocyclic GBCAs in children.
    Olchowy C; Maciąg EJ; Sanchez-Montanez A; Olchowy A; Delgado I; Vazquez E
    PLoS One; 2018; 13(12):e0208589. PubMed ID: 30586415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.